STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
· statnews.com · popularity 33/100 · 0 similar stories today
Read the original at statnews.com →
Summary
Dutch antitrust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 3.